ArticleBiomedicines2022

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model.

George V Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.